Gastroenterology Advisor

Gastroenterology Advisor is a valuable online platform designed for healthcare professionals, offering thorough insights into essential gastroenterology care practices. It also keeps users informed with the latest clinical updates regarding the diagnosis and treatment of various gastroenterological conditions. Key features include: - Daily news updates - In-depth articles covering significant gastroenterology topics - Real-time coverage of conferences - Insights and opinions from experts - Brief drug information sheets - Clinical charts for quick reference - Continuing medical education (CME) opportunities - And much more… Our goal is to provide the latest clinical research findings and evidence-based recommendations to help clinicians make well-informed decisions for their patients.

Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#546030

United States

#163661

Health/Medicine

#1295

Traffic sources

Monthly visitors

Articles

RETREAT Risk Score Predicted HCC Recurrence Post Liver Transplant

4 days ago | gastroenterologyadvisor.com | Colby Stong

The Risk Estimation of Tumor REcurrence After Transplant (RETREAT) score accurately predicted recurrence of hepatocellular carcinoma (HCC) post-liver transplantation, according to study results published in Hepatology.
Persistent Barrett Esophagus After USBE Boosts Dysplasia, Neoplasia Risk

1 week ago | gastroenterologyadvisor.com | Colby Stong

Patients with persistent Barrett esophagus (BE) after initial ultrashort Barrett esophagus diagnosis (USBE) on index endoscopy are at increased risk for developing dysplasia or neoplasia, according to results of a study published in the American Journal of Gastroenterology.
Exploring the Effects of Concomitant Hypothyroidism in Patients With IBD

1 week ago | gastroenterologyadvisor.com | Jessica Nye

Hypothyroidism concomitant with inflammatory bowel disease (IBD) was associated with increased risk for additional extraintestinal manifestations (EIMs) and greater health care use compared with having IBD alone, according to results of a study published in Digestive Diseases and Sciences. While the thyroid is the most commonly affected organ in patients with autoimmune diseases, such as IBD, the effects of concomitant hypothyroidism on patient outcomes is not fully understood.
Large Vessel Vasculitis in IBD Linked to Younger Onset, Distinct Clinical Features

1 week ago | gastroenterologyadvisor.com | Hibah Khaja

Patients with inflammatory bowel disease (IBD) who develop large vessel vasculitis (LVV) present with distinct clinical characteristics, including earlier onset and more severe vascular involvement, according to study findings published in Rheumatology. Takayasu arteritis (TA) and giant cell arteritis (GCA) are rare forms of LVV that affect the aorta and its branches.
Elevated Relative Fat Mass Linked to Increased Risk of Gallstones

2 weeks ago | gastroenterologyadvisor.com | Colby Stong

An elevated relative fat mass (RFM) was associated with an increased prevalence of gallstones in an assessment of data from the National Health and Nutrition Examination Survey (NHANES), according to findings published in BMC Gastroenterology. Gallstone disease affects close to 20% of the American and European population, with up to 25% of patients at risk of developing gallstone-related symptoms, some of which are life-threatening.
Preoperative GLP-1RA Use May Not Increase Risk for Aspiration Pneumonia

2 weeks ago | gastroenterologyadvisor.com | Jessica Nye

Preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) does not increase risk for postoperative aspiration pneumonia, according to results of a study published in JAMA Network Open. Risk for aspiration under anesthesia is a growing concern for GLP-1RA users due to the delaying of gastric emptying. In 2023, the American Society of Anesthesiologists (ASA) recommended discontinuation of GLP-1RAs for up to 1 week prior to surgery.
Younger Age and Drug Abuse Predict Readmission Risk in UC and CD

2 weeks ago | gastroenterologyadvisor.com | Jessica Nye

Sociodemographic and psychosocial characteristics can be utilized to predict readmission within 90 days among patients with ulcerative colitis (UC) or Crohn disease (CD). These findings were published in the Journal of Crohn’s and Colitis. Risk for readmission of patients with inflammatory bowel diseases (IBDs) is difficult to predict but is associated with a high-cost burden for patients and the United States health care system.
Hepatitis C Admissions Lower in Patients With HIV After DAA Access Expanded

2 weeks ago | gastroenterologyadvisor.com | Jessica Nye

Although expanded access to direct-acting antivirals (DAAs) has reduced hepatitis C virus (HCV)-related hospitalizations among patients with HIV, further efforts are needed to address disparities in clinical outcomes for those with HCV and HIV coinfection. These study results were published in Open Forum Infectious Diseases.
Advanced Age Predicted Mortality, Hepatic Encephalopathy at 1 Year Post TIPS

2 weeks ago | gastroenterologyadvisor.com | Colby Stong

In patients with cirrhosis, advanced age was associated with a higher rate of mortality and hepatic encephalopathy 1 year after receipt of a transjugular intrahepatic portosystemic shunt (TIPS); however, advanced age had less of a short-term impact on mortality and secondary complications following TIPS. These study results were published in the journal Digestive Diseases and Sciences.
Can Deep Learning ACE Score Predict Adverse Hepatic Outcomes in Cirrhosis?

2 weeks ago | gastroenterologyadvisor.com | Jessica Nye

A higher artificial intelligence (AI)-Cirrhosis-Electrocardiogram (ACE) score was significantly associated with mortality and liver transplant outcomes in patients with liver disease, according to an analysis of retrospective and prospective data published in JHEP Reports. The use of ACE scores also enhanced the predictive strength of Model for End-stage Liver Disease (MELD)-sodium (Na) scores in this setting.